hydralazine has been researched along with Cor Pulmonale in 12 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A two-year-old child dying of pulmonary hypertension and cor pulmonale secondary to bronchopulmonary dysplasia, was demonstrated to have reactive pulmonary hypertension in response to 100% oxygen and isoproterenol infusion." | 9.06 | Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia. ( Bingham, WT; Duncan, WJ; Kasian, GF; Mersal, A; Ninan, A; Sankaran, K; Tyrrell, MJ, 1988) |
| "Hydralazine was administered to eight patients (mean age, 69 +/- 2 years) who had stable, advanced chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension (mean pulmonary arterial pressure, 31 +/- 3 mm Hg), and cor pulmonale." | 7.67 | Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise. ( Lupi-Herrera, E; Seoane, M; Verdejo, J, 1984) |
| "Hydralazine was administered short-term to 13 patients who had stable interstitial lung disease (ILD), pulmonary arterial hypertension (PAH); mean pulmonary arterial pressure ( [PAP]=26 +/- 9 mm Hg), and cor pulmonale (CP)." | 7.67 | Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise. ( Barrios, R; Gomez, A; Lupi-Herrera, E; Martinez, W; Sandoval, J; Seoane, M; Verdejo, J, 1985) |
| "Oral hydralazine has been shown to be effective in decreasing pulmonary arteriolar resistance and increasing cardiac output in some patients with primary pulmonary hypertension." | 5.26 | Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale. ( Peter, RH; Rubin, LJ, 1981) |
| "A two-year-old child dying of pulmonary hypertension and cor pulmonale secondary to bronchopulmonary dysplasia, was demonstrated to have reactive pulmonary hypertension in response to 100% oxygen and isoproterenol infusion." | 5.06 | Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia. ( Bingham, WT; Duncan, WJ; Kasian, GF; Mersal, A; Ninan, A; Sankaran, K; Tyrrell, MJ, 1988) |
| "Hydralazine was administered to eight patients (mean age, 69 +/- 2 years) who had stable, advanced chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension (mean pulmonary arterial pressure, 31 +/- 3 mm Hg), and cor pulmonale." | 3.67 | Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise. ( Lupi-Herrera, E; Seoane, M; Verdejo, J, 1984) |
| "Hydralazine was administered short-term to 13 patients who had stable interstitial lung disease (ILD), pulmonary arterial hypertension (PAH); mean pulmonary arterial pressure ( [PAP]=26 +/- 9 mm Hg), and cor pulmonale (CP)." | 3.67 | Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise. ( Barrios, R; Gomez, A; Lupi-Herrera, E; Martinez, W; Sandoval, J; Seoane, M; Verdejo, J, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (75.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, MJ | 1 |
| Chappell, TR | 1 |
| Cook, W | 1 |
| De Olazabal, JR | 1 |
| Rubin, LJ | 2 |
| Rüegger, M | 1 |
| Medici, TC | 1 |
| Lupi-Herrera, E | 2 |
| Seoane, M | 2 |
| Verdejo, J | 2 |
| Fripp, RR | 1 |
| Gewitz, MH | 1 |
| Werner, JC | 1 |
| Whitman, V | 1 |
| Rashkind, WJ | 1 |
| Peter, RH | 1 |
| Vorob'ev, LP | 1 |
| Maev, IV | 1 |
| Lewczuk, J | 1 |
| Wrabec, K | 1 |
| Mar'iandyshev, AO | 1 |
| Evstaf'ev, IuA | 1 |
| Grigor'ev, IuG | 1 |
| Sun, BT | 1 |
| Kasian, GF | 1 |
| Ninan, A | 1 |
| Duncan, WJ | 1 |
| Bingham, WT | 1 |
| Mersal, A | 1 |
| Tyrrell, MJ | 1 |
| Sankaran, K | 1 |
| Gomez, A | 1 |
| Sandoval, J | 1 |
| Barrios, R | 1 |
| Martinez, W | 1 |
| Geggel, RL | 1 |
| Dozor, AJ | 1 |
| Fyler, DC | 1 |
| Reid, LM | 1 |
1 review available for hydralazine and Cor Pulmonale
| Article | Year |
|---|---|
[Value of vasodilator agents in the treatment of diseases with pulmonary hypertension caused by chronic obstructive lung diseases].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel B | 1991 |
2 trials available for hydralazine and Cor Pulmonale
| Article | Year |
|---|---|
[Effects of corinfar, nitrosorbide and apressin on external respiration and blood flow in chronic obstructive bronchitis].
Topics: Blood Circulation; Bronchitis; Humans; Hydralazine; Hypertension, Pulmonary; Isosorbide Dinitrate; N | 1992 |
Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia.
Topics: Albuterol; Bronchopulmonary Dysplasia; Child, Preschool; Diltiazem; Humans; Hydralazine; Hypertensio | 1988 |
9 other studies available for hydralazine and Cor Pulmonale
| Article | Year |
|---|---|
Effects of oral hydralazine on gas exchange in patients with cor pulmonale.
Topics: Administration, Oral; Adult; Aged; Blood Gas Analysis; Cardiac Output; Hemodynamics; Humans; Hydrala | 1983 |
[New therapies for cor pulmonale?].
Topics: Bloodletting; Humans; Hydralazine; Hypertension, Pulmonary; Hypoxia; Iron; Lung Diseases, Obstructiv | 1983 |
Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
Topics: Aged; Bronchitis; Hemodynamics; Humans; Hydralazine; Lung Diseases, Obstructive; Male; Middle Aged; | 1984 |
Oral hydralazine in patients with pulmonary vascular disease secondary to congenital heart disease.
Topics: Administration, Oral; Cardiac Output; Child; Child, Preschool; Female; Heart Defects, Congenital; He | 1981 |
Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Exercise Test; Female; Heart Rate; Hemodynamics; Humans | 1981 |
[Treatment of chronic cor pulmonale in pulmonary tuberculosis with apressin].
Topics: Antitubercular Agents; Hemodynamics; Humans; Hydralazine; Pulmonary Heart Disease; Tuberculosis, Pul | 1990 |
[Effect of hydralazine on the pulmonary arterial hypertension in monocrotaline induced cor pulmonale in Macacus rhesus].
Topics: Animals; Arterioles; Hydralazine; Hypertension, Pulmonary; Lung; Macaca mulatta; Monocrotaline; Pulm | 1987 |
Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
Topics: Administration, Oral; Adult; Blood Gas Analysis; Drug Administration Schedule; Female; Hemodynamics; | 1985 |
Effect of vasodilators at rest and during exercise in young adults with cystic fibrosis and chronic cor pulmonale.
Topics: Adult; Chronic Disease; Cystic Fibrosis; Exercise Test; Female; Hemodynamics; Humans; Hydralazine; M | 1985 |